/ /

Leah Lawrence
PD-1 inhibitor benefit possible even after discontinuation
Persistent clinical benefit was seen among a small group of patients with metastatic renal cell carcinoma who had to discontinue therapy with the PD-1 inhibitor nivolumab (Opdivo) because of immune-related adverse events, according to a study presented at the Genitourinary Cancers Symposium in Orlando, FL.
Antibiotics may negatively impact immunotherapy outcomes
Administration of broad-spectrum antibiotics in patients with metastatic renal cell carcinoma (RCC) undergoing treatment with immune checkpoint inhibitors may have a negative effect on the efficacy of the immunotherapy drugs, according to the results of a recent retrospective analysis.
High-deductible plan switch shows little effect on diabetes patients
New study indicates vulnerable subgroups of diabetes patients did experience adverse outcomes due to change in health insurance coverage.
CMS defines certain continuous glucose monitors as DME
New definition opens the door to full Medicare coverage for CGMs.
Diabetes accounts for majority of U.S. healthcare spending
Of 155 conditions, personal healthcare spending on diabetes tops list, according to new study.
HbA1c predicts diabetes risk in children
The easy-to-administer test was useful in predicting diabetes risk, and prediabetes status in children and adolescents.
Incidence, severity of COPD exacerbations increasing
French study shows that ICU admissions for and mortality from severe COPD exacerbations are increasing despite improved management methods.
Three-item questionnaire could help predict COPD exacerbation
In a small single-center study, a breathlessness, cough and sputum score of 5.0 or greater was a good predictor of exacerbation risk.
Two tools could help identify undiagnosed significant COPD
The CAPTURE questionnaire along with a peak flow test could assist primary care physicians with severe COPD diagnosis.
No link between long-term oxygen, improved mortality for stable COPD
Patients with stable COPD already using supplemental oxygen should discuss continued use with their physician.